Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Priority
Claims 1-20 are deemed to have an effective filing date of April 14, 2017 as the provisional applications do not support the “altering response characteristics” step .
Double Patenting
The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969).
A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b).
The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13.
The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer.
Claims 1-20 are rejected on the ground of nonstatutory double patenting as being unpatentable over claim 1 of U.S. Patent No. 12,285,602 (hereinafter “ ‘602” patent” in view of International Publication No. WO 2017/044967 to Taca, Jr. (EFD: 03/16/2017 and hereinafter referred to as Taca).
Instant claims 1-3 and 8 are encompassed by and conflicts with claim 1 of the ‘602 patent, except that it is directed to a method for treating anxiety and that it does not claim the steps of applying a stimulator device to the patient, producing an electrical signal from the stimulator device and the result clause: “thereby reducing pain …”. However, Taca teaches that electrical stimulation of a cranial nerve (vagus nerve) was known to those skilled in the art to treat addiction as well as to treat gastrointestinal motility and gastrointestinal tract disorder (e.g., Abstract, paragraphs [0002], [0007], [0062]-[0063], [0014]-[0015], and [0089] of Taca); and that anxiety is a typical withdrawal syndrome and a substance abuse-related condition treated by its invention (e.g., paragraphs [0062]-[0063] of Taca). Accordingly, one of ordinary skill in the art would have recognized the benefits of applying a stimulator device to a patient to treat a gastrointestinal order (e.g., paragraphs [0002]: stimulator applies electrical energy to a patient; [0091]: stimulation device 10 [and its unnumbered needle electrodes] is applied in the region of an ear 12 of a patient as depicted in Fig. 1A; and [0007]); producing an electrical signal from the stimulator device (e.g., paragraph [0091]: stimulation device 10 comprises an electrical signal generator 20 that generates electrical stimulation pulses), and that its electrical stimulation device reduces pain (e.g., paragraphs [0097]: electrical stimulation produces pain reduction; [0112]: certain stimulation therapies such as pain therapies for chronic disorders start with low values at the beginning of the treatment and slowly increase the intensity of the stimulation to the full extent) in view of the teachings of Taca. Consequently, one of ordinary skill in the art would have reasonably expected electrical stimulation of the cranial nerve using an electrical signal produced by a stimulator device applied to the patient to treat a functional gastrointestinal disorder and the pain associated thereof in view of the teachings of Taca. That is, one of ordinary skill in the art would have been motivated to at least try electrical stimulation of the cranial nerve to treat a functional gastrointestinal disorder and its associated pain since a person with ordinary skill has good reason to pursue the known options within his or her grasp. If this leads to the anticipated success, it is likely the product not of innovation but ordinary skill and commonsense (See KSR International Co. v. Teleflex, Inc., 550 U.S. 398 (2007)).
Instant claim 4 is encompassed by and conflicts with claim 1 of the ‘602 patent, as modified by Taca above. With respect to the step of locating the cranial nerve before the applying step, it is the Office Action’s position that the stimulation device should be placed near the cranial nerve as taught by Taca and thus, would be located prior to the applying step (e.g., paragraph [0084]: the stimulation device is arranged to deliver a series of electrical stimulation signals to a location based upon anatomical measurements of the patient; and [0106]-[0107]: the actual location and determination of needle placement and the location of application of electrical stimulation is based upon tradition and theory of acupuncture).
Instant claim 5 is encompassed by and conflicts with claim 1 of the ‘602 patent, as modified by Taca above. With respect to the step of percutaneously implanting at least one needle array into a dermis of the patient, Taca teaches that such as step was well-known in the electrical stimulation of the cranial nerve art (e.g., paragraph [0015]).
Instant claim 6 is encompassed by and conflicts with claim 1 of the ‘602 patent, as modified by Taca above. With respect to the step of implanting the at least one needle array into the dermis so that the at least one needle array is about 1 millimeter to about 2 millimeters from the cranial nerve, Taca teaches that the actual location and determination of needle placement is based on the anatomical location of cranial nerves and energy transfer laws including proximity to the actual nerves being stimulated (e.g., paragraph [0108]). It would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to modify the method of the ‘602 patent in view of Taca so that the needle array is from about 1 millimeter to about 2 millimeters from the cranial nerve, since it has been held that where the general conditions of a claim are disclosed in the prior art, discovering the optimum or workable ranges involves only routine skill in the art [In re Aller, 105 USPQ 233] and Applicant does not appear to provide criticality for the recited distance from the cranial nerve.
Instant claim 7 is encompassed by and conflicts with claim 1 of the ‘602 patent, as modified by Taca above. With respect to the at least one needle array including four needle arrays, Taca teaches that its stimulation device can comprise four or more needle arrays comprised of multiple needles each (e.g., paragraph [0090]). Accordingly, one of ordinary skill in the art would have recognized that a method for treating a gastrointestinal disorder can be achieved with four needle arrays in view of the teachings of Taca. Consequently, one of ordinary skill in the art would have further modified the method of the ‘602 patent as modified by Taca to implant four needle arrays in view of the teachings of Taca that such was a well-known expedient in the stimulation of the cranial nerve art, and because the combination would have yielded a predictable result.
Instant claim 9 is encompassed by and conflicts with claim 1 of the ‘602 patent, as modified by Taca above. With respect to the step of stimulating the cranial nerve percutaneously, Taca teaches inserting needle electrodes into the skin surface of an area to be stimulated where the needle electrode array is designed for auricular peripheral cranial nerve field stimulation (e.g., paragraph [0075]). Accordingly, one of ordinary skill in the art would have recognized that a method for treating a gastrointestinal disorder can be achieved by stimulating the cranial nerve percutaneously in view of the teachings of Taca. Consequently, one of ordinary skill in the art would have further modified the method of the ‘602 patent as modified by Taca to percutaneously stimulate the cranial nerve in view of the teachings of Taca that such was a well-known expedient in the stimulation of the cranial nerve art, and because the combination would have yielded a predictable result.
Instant claim 10 is encompassed by and conflict with claim 1 of the ‘602 patent as modified by Taca. With respect to the value of voltage for the electrical stimulation signal, Taca teaches that the voltage output of its stimulation device is in the range of .0001 volts to 6 volts (e.g., paragraph [0077]). Accordingly, one of ordinary skill in the art would have recognized that a method for treating a gastrointestinal disorder can be achieved with a stimulation device output a voltage between about 1 V and about 5 V in view of the teachings of Taca. Consequently, one of ordinary skill in the art would have further modified the method of the ‘602 patent as modified by Taca to have the recited electrical stimulation signal value in view of the teachings of Taca that such was a well-known expedient in the stimulation of the cranial nerve art, and because the combination would have yielded a predictable result.
Instant claims 11-13 are encompassed by and conflict with claim 1 of the ‘602 patent as modified by Taca. With respect to the values of repetition frequency and duty cycle, Taca further teaches that values within the claim ranges (e.g., paragraph [0076]). Accordingly, one of ordinary skill in the art would have recognized that a method for treating a gastrointestinal disorder can be achieved by stimulating the cranial nerve with a repetition frequency between 0.5 Hz to 300 Hz or a duty cycle of 5-100% in view of the teachings of Taca. Consequently, one of ordinary skill in the art would have further modified the method of the ‘602 patent as modified by Taca to stimulate the cranial nerve with the recited repetition frequency and duty cycle in view of the teachings of Taca that such was a well-known expedient in the stimulation of the cranial nerve art, and because the combination would have yielded a predictable result.
Instant claims 14-17, 18 and 19-20 are encompassed by and conflict with claims 2-5, 7, and 9-10 of the ‘602 patent as modified by Taca.
Claims 1-20 are rejected on the ground of nonstatutory double patenting as being unpatentable over claim 1 of U.S. Patent No. 11,813,448 in view of Taca.
Instant claims 1-3 and 8 are encompassed by and conflicts with claim 1 of the ‘602 patent, except that it is directed to for a “disease” and it does not recite the steps of applying a stimulator device to the patient, producing an electrical signal from the stimulator device and the result clause: “thereby reducing pain …”. However, Taca teaches that electrical stimulation of a cranial nerve (vagus nerve) was known to those skilled in the art to treat addiction as well as to treat the claimed gastrointestinal motility and gastrointestinal tract disorder (e.g., Abstract, paragraphs [0002], [0007], [0062]-[0063], [0014]-[0015], and [0089] of Taca). Accordingly, one of ordinary skill in the art would have recognized the benefits of applying a stimulator device to a patient (e.g., paragraphs [0002]: stimulator applies electrical energy to a patient; [0091]: stimulation device 10 [and its unnumbered needle electrodes] is applied in the region of an ear 12 of a patient as depicted in Fig. 1A); producing an electrical signal from the stimulator device (e.g., paragraph [0091]: stimulation device 10 comprises an electrical signal generator 20 that generates electrical stimulation pulses), and that its electrical stimulation device reduces pain (e.g., paragraphs [0097]: electrical stimulation produces pain reduction; [0112]: certain stimulation therapies such as pain therapies for chronic disorders start with low values at the beginning of the treatment and slowly increase the intensity of the stimulation to the full extent). Consequently, one of ordinary skill in the art would have reasonably expected electrical stimulation of the cranial nerve using an electrical signal produced by a stimulator device applied to the patient to treat a functional gastrointestinal disorder and the pain associated thereof in view of the teachings of Taca. That is, one of ordinary skill in the art would have been motivated to at least try electrical stimulation of the cranial nerve to treat a functional gastrointestinal disorder and its associated pain since a person with ordinary skill has good reason to pursue the known options within his or her grasp. If this leads to the anticipated success, it is likely the product not of innovation but ordinary skill and commonsense (See KSR International Co. v. Teleflex, Inc., 550 U.S. 398 (2007)).
Instant claim 4 is encompassed by and conflicts with claim 1 of the ‘602 patent, as modified by Taca above. With respect to the step of locating the cranial nerve before the applying step, it is the Office Action’s position that the stimulation device should be placed near the cranial nerve as taught by Taca and thus, would be located prior to the applying step (e.g., paragraph [0084]: the stimulation device is arranged to deliver a series of electrical stimulation signals to a location based upon anatomical measurements of the patient; and [0106]-[0107]: the actual location and determination of needle placement and the location of application of electrical stimulation is based upon tradition and theory of acupuncture).
Instant claim 5 is encompassed by and conflicts with claim 1 of the ‘602 patent, as modified by Taca above. With respect to the step of percutaneously implanting at least one needle array into a dermis of the patient, Taca teaches that such as step was well-known in the electrical stimulation of the cranial nerve art (e.g., paragraph [0015]).
Instant claim 6 is encompassed by and conflicts with claim 1 of the ‘602 patent, as modified by Taca above. With respect to the step of implanting the at least one needle array into the dermis so that the at least one needle array is about 1 millimeter to about 2 millimeters from the cranial nerve, Taca teaches that the actual location and determination of needle placement is based on the anatomical location of cranial nerves and energy transfer laws including proximity to the actual nerves being stimulated (e.g., paragraph [0108]). It would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to modify the method of the ‘602 patent in view of Taca so that the needle array is from about 1 millimeter to about 2 millimeters from the cranial nerve, since it has been held that where the general conditions of a claim are disclosed in the prior art, discovering the optimum or workable ranges involves only routine skill in the art [In re Aller, 105 USPQ 233] and Applicant does not appear to provide criticality for the recited distance from the cranial nerve.
Instant claim 7 is encompassed by and conflicts with claim 1 of the ‘602 patent, as modified by Taca above. With respect to the at least one needle array including four needle arrays, Taca teaches that its stimulation device can comprise four or more needle arrays comprised of multiple needles each (e.g., paragraph [0090]). Accordingly, one of ordinary skill in the art would have recognized that a method for treating a gastrointestinal disorder can be achieved with four needle arrays in view of the teachings of Taca. Consequently, one of ordinary skill in the art would have further modified the method of the ‘602 patent as modified by Taca to implant four needle arrays in view of the teachings of Taca that such was a well-known expedient in the stimulation of the cranial nerve art, and because the combination would have yielded a predictable result.
Instant claim 9 is encompassed by and conflicts with claim 1 of the ‘602 patent, as modified by Taca above. With respect to the step of stimulating the cranial nerve percutaneously, Taca teaches inserting needle electrodes into the skin surface of an area to be stimulated where the needle electrode array is designed for auricular peripheral cranial nerve field stimulation (e.g., paragraph [0075]). Accordingly, one of ordinary skill in the art would have recognized that a method for treating a gastrointestinal disorder can be achieved by stimulating the cranial nerve percutaneously in view of the teachings of Taca. Consequently, one of ordinary skill in the art would have further modified the method of the ‘602 patent as modified by Taca to percutaneously stimulate the cranial nerve in view of the teachings of Taca that such was a well-known expedient in the stimulation of the cranial nerve art, and because the combination would have yielded a predictable result.
Instant claim 10 is encompassed by and conflict with claim 1 of the ‘602 patent as modified by Taca. With respect to the value of voltage for the electrical stimulation signal, Taca teaches that the voltage output of its stimulation device is in the range of .0001 volts to 6 volts (e.g., paragraph [0077]). Accordingly, one of ordinary skill in the art would have recognized that a method for treating a gastrointestinal disorder can be achieved with a stimulation device output a voltage between about 1 V and about 5 V in view of the teachings of Taca. Consequently, one of ordinary skill in the art would have further modified the method of the ‘602 patent as modified by Taca to have the recited electrical stimulation signal value in view of the teachings of Taca that such was a well-known expedient in the stimulation of the cranial nerve art, and because the combination would have yielded a predictable result.
Instant claims 11-13 are encompassed by and conflict with claim 1 of the ‘602 patent as modified by Taca. With respect to the values of repetition frequency and duty cycle, Taca further teaches that values within the claim ranges (e.g., paragraph [0076]). Accordingly, one of ordinary skill in the art would have recognized that a method for treating a gastrointestinal disorder can be achieved by stimulating the cranial nerve with a repetition frequency between 0.5 Hz to 300 Hz or a duty cycle of 5-100% in view of the teachings of Taca. Consequently, one of ordinary skill in the art would have further modified the method of the ‘602 patent as modified by Taca to stimulate the cranial nerve with the recited repetition frequency and duty cycle in view of the teachings of Taca that such was a well-known expedient in the stimulation of the cranial nerve art, and because the combination would have yielded a predictable result.
Instant claims 14-20 are encompassed by and conflict with claim 1 of the ‘602 patent as modified by Taca. With respect to the particular cranial nerve being stimulated, Taca discloses that electrode/needle array implantation into the skin of the ear allows for access to branches of cranial nerves V, VII, IX, and X as well as branches of the occipital nerves (e.g., paragraph [0104]) and that cranial nerves V, VII, IX, X directly connect into the brain and branches of greater and less occipital nerves connect directly into the cervical spine as well as the ear has a concentration of the cranial nerves and neurovascular bundles (e.g., paragraph [0109]). Accordingly, one of ordinary skill in the art would have recognized that a method for treating a gastrointestinal disorder can be achieved by stimulating the cranial nerve percutaneously in view of the teachings of Taca. Consequently, one of ordinary skill in the art would have further modified the method of the ‘602 patent as modified by Taca to stimulate a cranial nerve selected from V, VII, IX, X and branches of greater and less occipital nerves thereof and their associated neurovascular bundles in view of the teachings of Taca that such was a well-known expedient in the stimulation of the cranial nerve art, and because the combination would have yielded a predictable result.
Claims 1-20 are rejected on the ground of nonstatutory double patenting as being unpatentable over claim 1 of U.S. Patent No. 11,331,473 in view of Taca.
Instant claims 1-3 and 8 are encompassed by and conflicts with claim 1 of the ‘602 patent, except that it does not recite the steps of applying a stimulator device to the patient, producing an electrical signal from the stimulator device and the result clause: “thereby reducing pain …”. However, Taca teaches that electrical stimulation of a cranial nerve (vagus nerve) was known to those skilled in the art to treat addiction as well as to treat the claimed gastrointestinal motility and gastrointestinal tract disorder (e.g., Abstract, paragraphs [0002], [0007], [0062]-[0063], [0014]-[0015], and [0089] of Taca). Accordingly, one of ordinary skill in the art would have recognized the benefits of applying a stimulator device to a patient (e.g., paragraphs [0002]: stimulator applies electrical energy to a patient; [0091]: stimulation device 10 [and its unnumbered needle electrodes] is applied in the region of an ear 12 of a patient as depicted in Fig. 1A); producing an electrical signal from the stimulator device (e.g., paragraph [0091]: stimulation device 10 comprises an electrical signal generator 20 that generates electrical stimulation pulses), and that its electrical stimulation device reduces pain (e.g., paragraphs [0097]: electrical stimulation produces pain reduction; [0112]: certain stimulation therapies such as pain therapies for chronic disorders start with low values at the beginning of the treatment and slowly increase the intensity of the stimulation to the full extent). Consequently, one of ordinary skill in the art would have reasonably expected electrical stimulation of the cranial nerve using an electrical signal produced by a stimulator device applied to the patient to treat a functional gastrointestinal disorder and the pain associated thereof in view of the teachings of Taca. That is, one of ordinary skill in the art would have been motivated to at least try electrical stimulation of the cranial nerve to treat a functional gastrointestinal disorder and its associated pain since a person with ordinary skill has good reason to pursue the known options within his or her grasp. If this leads to the anticipated success, it is likely the product not of innovation but ordinary skill and commonsense (See KSR International Co. v. Teleflex, Inc., 550 U.S. 398 (2007)).
Instant claim 4 is encompassed by and conflicts with claim 1 of the ‘602 patent, as modified by Taca above. With respect to the step of locating the cranial nerve before the applying step, it is the Office Action’s position that the stimulation device should be placed near the cranial nerve as taught by Taca and thus, would be located prior to the applying step (e.g., paragraph [0084]: the stimulation device is arranged to deliver a series of electrical stimulation signals to a location based upon anatomical measurements of the patient; and [0106]-[0107]: the actual location and determination of needle placement and the location of application of electrical stimulation is based upon tradition and theory of acupuncture).
Instant claim 5 is encompassed by and conflicts with claim 1 of the ‘602 patent, as modified by Taca above. With respect to the step of percutaneously implanting at least one needle array into a dermis of the patient, Taca teaches that such as step was well-known in the electrical stimulation of the cranial nerve art (e.g., paragraph [0015]).
Instant claim 6 is encompassed by and conflicts with claim 1 of the ‘602 patent, as modified by Taca above. With respect to the step of implanting the at least one needle array into the dermis so that the at least one needle array is about 1 millimeter to about 2 millimeters from the cranial nerve, Taca teaches that the actual location and determination of needle placement is based on the anatomical location of cranial nerves and energy transfer laws including proximity to the actual nerves being stimulated (e.g., paragraph [0108]). It would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to modify the method of the ‘602 patent in view of Taca so that the needle array is from about 1 millimeter to about 2 millimeters from the cranial nerve, since it has been held that where the general conditions of a claim are disclosed in the prior art, discovering the optimum or workable ranges involves only routine skill in the art [In re Aller, 105 USPQ 233] and Applicant does not appear to provide criticality for the recited distance from the cranial nerve.
Instant claim 7 is encompassed by and conflicts with claim 1 of the ‘602 patent, as modified by Taca above. With respect to the at least one needle array including four needle arrays, Taca teaches that its stimulation device can comprise four or more needle arrays comprised of multiple needles each (e.g., paragraph [0090]). Accordingly, one of ordinary skill in the art would have recognized that a method for treating a gastrointestinal disorder can be achieved with four needle arrays in view of the teachings of Taca. Consequently, one of ordinary skill in the art would have further modified the method of the ‘602 patent as modified by Taca to implant four needle arrays in view of the teachings of Taca that such was a well-known expedient in the stimulation of the cranial nerve art, and because the combination would have yielded a predictable result.
Instant claim 9 is encompassed by and conflicts with claim 1 of the ‘602 patent, as modified by Taca above. With respect to the step of stimulating the cranial nerve percutaneously, Taca teaches inserting needle electrodes into the skin surface of an area to be stimulated where the needle electrode array is designed for auricular peripheral cranial nerve field stimulation (e.g., paragraph [0075]). Accordingly, one of ordinary skill in the art would have recognized that a method for treating a gastrointestinal disorder can be achieved by stimulating the cranial nerve percutaneously in view of the teachings of Taca. Consequently, one of ordinary skill in the art would have further modified the method of the ‘602 patent as modified by Taca to percutaneously stimulate the cranial nerve in view of the teachings of Taca that such was a well-known expedient in the stimulation of the cranial nerve art, and because the combination would have yielded a predictable result.
Instant claim 10 is encompassed by and conflict with claim 1 of the ‘602 patent as modified by Taca. With respect to the value of voltage for the electrical stimulation signal, Taca teaches that the voltage output of its stimulation device is in the range of .0001 volts to 6 volts (e.g., paragraph [0077]). Accordingly, one of ordinary skill in the art would have recognized that a method for treating a gastrointestinal disorder can be achieved with a stimulation device output a voltage between about 1 V and about 5 V in view of the teachings of Taca. Consequently, one of ordinary skill in the art would have further modified the method of the ‘602 patent as modified by Taca to have the recited electrical stimulation signal value in view of the teachings of Taca that such was a well-known expedient in the stimulation of the cranial nerve art, and because the combination would have yielded a predictable result.
Instant claims 11-13 are encompassed by and conflict with claim 1 of the ‘602 patent as modified by Taca. With respect to the values of repetition frequency and duty cycle, Taca further teaches that values within the claim ranges (e.g., paragraph [0076]). Accordingly, one of ordinary skill in the art would have recognized that a method for treating a gastrointestinal disorder can be achieved by stimulating the cranial nerve with a repetition frequency between 0.5 Hz to 300 Hz or a duty cycle of 5-100% in view of the teachings of Taca. Consequently, one of ordinary skill in the art would have further modified the method of the ‘602 patent as modified by Taca to stimulate the cranial nerve with the recited repetition frequency and duty cycle in view of the teachings of Taca that such was a well-known expedient in the stimulation of the cranial nerve art, and because the combination would have yielded a predictable result.
Instant claims 14-20 are encompassed by and conflict with claim 1 of the ‘602 patent as modified by Taca. With respect to the particular cranial nerve being stimulated, Taca discloses that electrode/needle array implantation into the skin of the ear allows for access to branches of cranial nerves V, VII, IX, and X as well as branches of the occipital nerves (e.g., paragraph [0104]) and that cranial nerves V, VII, IX, X directly connect into the brain and branches of greater and less occipital nerves connect directly into the cervical spine as well as the ear has a concentration of the cranial nerves and neurovascular bundles (e.g., paragraph [0109]). Accordingly, one of ordinary skill in the art would have recognized that a method for treating a gastrointestinal disorder can be achieved by stimulating the cranial nerve percutaneously in view of the teachings of Taca. Consequently, one of ordinary skill in the art would have further modified the method of the ‘602 patent as modified by Taca to stimulate a cranial nerve selected from V, VII, IX, X and branches of greater and less occipital nerves thereof and their associated neurovascular bundles in view of the teachings of Taca that such was a well-known expedient in the stimulation of the cranial nerve art, and because the combination would have yielded a predictable result.
Claims 1-20 are rejected on the ground of nonstatutory double patenting as being unpatentable over claim 1 of U.S. Patent No. 10,413,719 in view of Taca.
Instant claims 1-3 and 8 are encompassed by and conflicts with claim 1 of the ‘602 patent, except that it is directed to for a “treating a withdrawal symptom in a patient” and it does not recite the steps of applying a stimulator device to the patient, producing an electrical signal from the stimulator device and the result clause: “thereby reducing pain …”. However, Taca teaches that electrical stimulation of a cranial nerve (vagus nerve) was known to those skilled in the art to treat addiction as well as to treat the claimed gastrointestinal motility and gastrointestinal tract disorder (e.g., Abstract, paragraphs [0002], [0007], [0062]-[0063], [0014]-[0015], and [0089] of Taca). Accordingly, one of ordinary skill in the art would have recognized the benefits of applying a stimulator device to a patient (e.g., paragraphs [0002]: stimulator applies electrical energy to a patient; [0091]: stimulation device 10 [and its unnumbered needle electrodes] is applied in the region of an ear 12 of a patient as depicted in Fig. 1A); producing an electrical signal from the stimulator device (e.g., paragraph [0091]: stimulation device 10 comprises an electrical signal generator 20 that generates electrical stimulation pulses), and that its electrical stimulation device reduces pain (e.g., paragraphs [0097]: electrical stimulation produces pain reduction; [0112]: certain stimulation therapies such as pain therapies for chronic disorders start with low values at the beginning of the treatment and slowly increase the intensity of the stimulation to the full extent). Consequently, one of ordinary skill in the art would have reasonably expected electrical stimulation of the cranial nerve using an electrical signal produced by a stimulator device applied to the patient to treat a functional gastrointestinal disorder and the pain associated thereof in view of the teachings of Taca. That is, one of ordinary skill in the art would have been motivated to at least try electrical stimulation of the cranial nerve to treat a functional gastrointestinal disorder and its associated pain since a person with ordinary skill has good reason to pursue the known options within his or her grasp. If this leads to the anticipated success, it is likely the product not of innovation but ordinary skill and commonsense (See KSR International Co. v. Teleflex, Inc., 550 U.S. 398 (2007)).
Instant claim 4 is encompassed by and conflicts with claim 1 of the ‘602 patent, as modified by Taca above. With respect to the step of locating the cranial nerve before the applying step, it is the Office Action’s position that the stimulation device should be placed near the cranial nerve as taught by Taca and thus, would be located prior to the applying step (e.g., paragraph [0084]: the stimulation device is arranged to deliver a series of electrical stimulation signals to a location based upon anatomical measurements of the patient; and [0106]-[0107]: the actual location and determination of needle placement and the location of application of electrical stimulation is based upon tradition and theory of acupuncture).
Instant claim 5 is encompassed by and conflicts with claim 1 of the ‘602 patent, as modified by Taca above. With respect to the step of percutaneously implanting at least one needle array into a dermis of the patient, Taca teaches that such as step was well-known in the electrical stimulation of the cranial nerve art (e.g., paragraph [0015]).
Instant claim 6 is encompassed by and conflicts with claim 1 of the ‘602 patent, as modified by Taca above. With respect to the step of implanting the at least one needle array into the dermis so that the at least one needle array is about 1 millimeter to about 2 millimeters from the cranial nerve, Taca teaches that the actual location and determination of needle placement is based on the anatomical location of cranial nerves and energy transfer laws including proximity to the actual nerves being stimulated (e.g., paragraph [0108]). It would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to modify the method of the ‘602 patent in view of Taca so that the needle array is from about 1 millimeter to about 2 millimeters from the cranial nerve, since it has been held that where the general conditions of a claim are disclosed in the prior art, discovering the optimum or workable ranges involves only routine skill in the art [In re Aller, 105 USPQ 233] and Applicant does not appear to provide criticality for the recited distance from the cranial nerve.
Instant claim 7 is encompassed by and conflicts with claim 1 of the ‘602 patent, as modified by Taca above. With respect to the at least one needle array including four needle arrays, Taca teaches that its stimulation device can comprise four or more needle arrays comprised of multiple needles each (e.g., paragraph [0090]). Accordingly, one of ordinary skill in the art would have recognized that a method for treating a gastrointestinal disorder can be achieved with four needle arrays in view of the teachings of Taca. Consequently, one of ordinary skill in the art would have further modified the method of the ‘602 patent as modified by Taca to implant four needle arrays in view of the teachings of Taca that such was a well-known expedient in the stimulation of the cranial nerve art, and because the combination would have yielded a predictable result.
Instant claim 9 is encompassed by and conflicts with claim 1 of the ‘602 patent, as modified by Taca above. With respect to the step of stimulating the cranial nerve percutaneously, Taca teaches inserting needle electrodes into the skin surface of an area to be stimulated where the needle electrode array is designed for auricular peripheral cranial nerve field stimulation (e.g., paragraph [0075]). Accordingly, one of ordinary skill in the art would have recognized that a method for treating a gastrointestinal disorder can be achieved by stimulating the cranial nerve percutaneously in view of the teachings of Taca. Consequently, one of ordinary skill in the art would have further modified the method of the ‘602 patent as modified by Taca to percutaneously stimulate the cranial nerve in view of the teachings of Taca that such was a well-known expedient in the stimulation of the cranial nerve art, and because the combination would have yielded a predictable result.
Instant claim 10 is encompassed by and conflict with claim 1 of the ‘602 patent as modified by Taca. With respect to the value of voltage for the electrical stimulation signal, Taca teaches that the voltage output of its stimulation device is in the range of .0001 volts to 6 volts (e.g., paragraph [0077]). Accordingly, one of ordinary skill in the art would have recognized that a method for treating a gastrointestinal disorder can be achieved with a stimulation device output a voltage between about 1 V and about 5 V in view of the teachings of Taca. Consequently, one of ordinary skill in the art would have further modified the method of the ‘602 patent as modified by Taca to have the recited electrical stimulation signal value in view of the teachings of Taca that such was a well-known expedient in the stimulation of the cranial nerve art, and because the combination would have yielded a predictable result.
Instant claims 11-13 are encompassed by and conflict with claim 1 of the ‘602 patent as modified by Taca. With respect to the values of repetition frequency and duty cycle, Taca further teaches that values within the claim ranges (e.g., paragraph [0076]). Accordingly, one of ordinary skill in the art would have recognized that a method for treating a gastrointestinal disorder can be achieved by stimulating the cranial nerve with a repetition frequency between 0.5 Hz to 300 Hz or a duty cycle of 5-100% in view of the teachings of Taca. Consequently, one of ordinary skill in the art would have further modified the method of the ‘602 patent as modified by Taca to stimulate the cranial nerve with the recited repetition frequency and duty cycle in view of the teachings of Taca that such was a well-known expedient in the stimulation of the cranial nerve art, and because the combination would have yielded a predictable result.
Instant claims 14-20 are encompassed by and conflict with claim 1 of the ‘602 patent as modified by Taca. With respect to the particular cranial nerve being stimulated, Taca discloses that electrode/needle array implantation into the skin of the ear allows for access to branches of cranial nerves V, VII, IX, and X as well as branches of the occipital nerves (e.g., paragraph [0104]) and that cranial nerves V, VII, IX, X directly connect into the brain and branches of greater and less occipital nerves connect directly into the cervical spine as well as the ear has a concentration of the cranial nerves and neurovascular bundles (e.g., paragraph [0109]). Accordingly, one of ordinary skill in the art would have recognized that a method for treating a gastrointestinal disorder can be achieved by stimulating the cranial nerve percutaneously in view of the teachings of Taca. Consequently, one of ordinary skill in the art would have further modified the method of the ‘602 patent as modified by Taca to stimulate a cranial nerve selected from V, VII, IX, X and branches of greater and less occipital nerves thereof and their associated neurovascular bundles in view of the teachings of Taca that such was a well-known expedient in the stimulation of the cranial nerve art, and because the combination would have yielded a predictable result.
Conclusion
The prior art made of record and not relied upon is considered pertinent to applicant's disclosure.
US Patent Application Publication No. 2013/0131753 to Simon et al. is directed to electrical nerve stimulation to treat gastroparesis, functional dyspepsia, and other functional gastrointestinal disorders (e.g., title and paragraphs [0014]-[0015]) where the electrical stimulation is applied to a patient to stimulate a vagus nerve (e.g., abstract, and paragraphs [0006] and [0011]).
US Patent Application Publication No. 2006/0069415 to Cameron et al. is directed to electrical stimulation of a nerve including the vagal nerve (e.g., title and paragraph [0046]).
Any inquiry concerning this communication or earlier communications from the examiner should be directed to CATHERINE M VOORHEES whose telephone number is (571)270-3846. The examiner can normally be reached Monday-Friday 8:30 AM to 4:30 PM.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Unsu Jung can be reached at 571 272-8506. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/CATHERINE M VOORHEES/Primary Examiner, Art Unit 3792